Drug Importation Debate Highlights Need For Lower Rx Prices - CMS Administrator
This article was originally published in The Pink Sheet Daily
Executive Summary
The findings of the HHS importation task force and the new Medicare drug benefit will lead to lower prices for consumers, CMS Administrator McClellan tells NACDS. Fairer international pricing, including reduced prices of generics in other countries, is also a way forward, he adds.